SURMODICS INC — Director's Dealing 2018

Nov 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2018-11-01

Reporting Person: Maharaj Gary R (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-01	Common Stock	S	4193	$62.1251	Disposed	166086	Direct
2018-11-01	Common Stock	S	807	$62.6427	Disposed	165279	Direct

Footnotes

F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.

F2: Reflects the weighted average price of 4,193 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on November 1, 2018 with sale prices ranging from $61.50 to $62.43 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Reflects the weighted average price of 807 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on November 1, 2018 with sale prices ranging from $62.51 to $63.085 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.